NOVAVAX INC (NVAX)

US6700024010 - Common Stock

4.19  +0.12 (+2.95%)

After market: 4.02 -0.17 (-4.06%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.146B
141.02%		1.982B
72.90%		983.705M
-50.37%		866.65M
-11.90%
EBITDA
YoY % growth
-1.674B
-306.48%		-615.6M
63.22%		-510.986M
16.99%		-113.705M
77.75%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-1.687B
-304.75%		-644.7M
61.78%		-552.211M
14.35%		-136.93M
75.20%
Operating Margin
-147.13%-32.53%-56.14%-15.80%
EPS
YoY % growth
-23.29
-243.00%		-8.40
63.93%		-5.53
34.17%		-0.81
85.31%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.94
72.54%
Revenue
Q2Q % growth		103.48M
27.75%
EBITDA
Q2Q % growth		-151.98M
EBIT
Q2Q % growth		-119.034M
61.95%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -1.44
36.84%		-0.46-0.98-214.89%
Q3 2023
Q2Q % growth		 -1.26
41.40%		-1.870.6132.56%
Q2 2023
Q2Q % growth		 0.58
108.88%		-1.411.99141.01%
Q1 2023
Q2Q % growth		 -3.41
-233.20%		-3.530.123.43%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 291.342M
-18.48%		328.41M-37.068M-11.29%
Q3 2023
Q2Q % growth		 187M
-74.54%		161.71M25.29M15.64%
Q2 2023
Q2Q % growth		 424.4M
128.29%		243.94M180.46M73.98%
Q1 2023
Q2Q % growth		 81M
-88.49%		89.364M-8.364M-9.36%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS3.16% -170% 12.61% -9.89%
Revenue0% -66.18% -0.33% -18.32%